Triethylamine → HCID 57883815, compound

HRID 2263801Notes

Reaction equation

HRID 2263801 reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([N:14]([CH:25]2[CH2:30][CH2:29][CH:28]([CH3:31])[CH2:27][CH2:26]2)[C:15]([NH:17][C:18]2[S:19][C:20]([CH:23]=O)=[CH:21][N:22]=2)=[O:16])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl.N1([CH2:39][CH2:40][S:41]([NH2:44])(=[O:43])=[O:42])CCNCC1.C([N:47]([CH2:50][CH3:51])[CH2:48][CH3:49])C.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>>[C:1]([O:5][C:6]([N:8]1[CH2:9][CH2:10][CH:11]([N:14]([CH:25]2[CH2:26][CH2:27][CH:28]([CH3:31])[CH2:29][CH2:30]2)[C:15]([NH:17][C:18]2[S:19][C:20]([CH2:23][N:47]3[CH2:48][CH2:49][N:44]([S:41]([CH2:40][CH3:39])(=[O:43])=[O:42])[CH2:51][CH2:50]3)=[CH:21][N:22]=2)=[O:16])[CH2:12][CH2:13]1)=[O:7])([CH3:3])([CH3:2])[CH3:4]

Participants

5

Procedure

Prepared as described in general procedure (P) using 4-[3-(5-formyl-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-ureido]-piperidine-1-carboxylic acid tert-butyl ester (200 mg, 0.45 mmol), piperazine ethane sulfonamide hydrochloride (125 mg, 0.58 mmol), triethyl amine (80 μL, 0.58 mmol) and sodium triacetoxyborohydride (113 mg, 0.53 mmol) to afford 160 mg (58%) of the desired product after purification.

Workup

  1. customPrepared

Sources & evidence

ORD record
ord-d2e6df00ce0e4c4fa7ccd438ad7d26da
Source dataset
uspto-grants-2010_12
Patent number
US07851636B2

Reaction notes

Loading…